CMB International Securities | Equity Research | Company Update
A Wholly Owned Subsidiary Of China Merchants Bank
China Everbright Bank (601818 CH)
BUY (Maintain)
Subdued profit; Highlights on fees and asset quality
Target Price
(Previous TP
RMB 5.50)
Up/Downside
+28.9%
CEB's net profit declined 29.7%/10.2% YoY in 2Q/1H20, primarily due to heavy
Current Price
provisions (+54.9% YoY) amid kitchen-sinking in 2Q20. We expect manageable
asset quality risk ahead, given lower overdue/SML ratio and sequential pick-up
China Banking Sector
in provision coverage. Net interest income growth was decent at 10.3% YoY, on
solid credit expansion and largely stable margin. As the first Chinese joint-stock
Terry Sun, CFA
bank to set up wealth management subsidiary in Sep 2019, CEB saw achieved
a strong recovery in wealth management service fee (+450% YoY), leading to
17.3% YoY total fee income growth in 1H20.
Stock Data
Mkt Cap (RMB mn)
186,923
■ Results positives: 1) Deposit growth was solid at 4.0% QoQ. LDR
Avg 3 mths t/o (RMB mn)
retreated 2.4ppt QoQ to 79.6%, the lowest among joint-stock banks under our
52w High/Low (RMB)
4.8/3.48
coverage. 2) Asset quality improved. NPL ratio remained flat at 1.55%, and
39,811 (A)
Total Issued Shares (mn)
provision coverage climbed 4.6ppt QoQ to 186.8%. As the leading indicators
Source: Bloomberg
for asset quality trend, both overdue loan and SML ratio declined moderately,
suggesting easing NPL pressure ahead. 3) Net fee income rose 17.3% YoY
Shareholding Structure
in 2Q20, mainly driven by wealth management and settlement & clearing
businesses. 4) Cost-income ratio fell 0.7ppt YoY to 27.8% in 2Q20.
Results negatives: 1) Loan growth slowed to 0.9% in 2Q20, from 6.7% in
1Q20. Corporate loans and personal mortgage increased 11.4%/6.4% in
Share Performance
1H20, but growth in credit card and other retail loans stay muted due to
COVID-19's impact. 2) 2Q20 NIM narrowed 2bp QoQ to 2.29% based on our
estimate. Corporate loan and investment yields slid 8bp/6bp in 1H20, but that
of retail loans was largely stable. On liability side, interbank funding cost fell
31bp HoH during monetary loosening, more than offsetting deposit cost hike
of 8bp HoH. 3) Capital position weakened, as CET1/total CAR dropped
12-mth Price Performance
36bp/35bp QoQ to 8.68%/12.74% on soft earnings and cash dividend payout.
The outstanding RMB30bn CB could boost capital ratio by 80bp after full
conversion.
Maintain BUY with lower TP of RMB5.0. We cut FY20/21 earnings forecasts
by 13-14%, to reflect lower NIM/fee income and higher credit cost
assumptions. Our revised TP of HK$4.0 is based on 0.78x (from 0.84x) target
P/B and FY20 BVPS of RMB6.45.
Source: Bloomberg
Earnings Summary
Auditor: Ernst & Young
Related Reports
Cloud Payment – A booster for
digital transformation - 30 May
Earnings momentum to sustain;
Source: Company data, CMBIS
Source: Company data
Source: Company data
Source: CMBIS estimates
Financial Summary
Source: Company data, CMBIS estimates
Disclosures & Disclaimers
Analyst Certification
The research analyst who is primary responsible for the content of this research report, in whole or in part, certifies that with respect to the securities
or issuer that the analyst covered in this report: (1) all of the views expressed accurately reflect his or her personal views about the subject securities
or issuer; and (2) no part of his or her compensation was, is, or will be, directly or indirectly, related to the specific views expressed by that analyst
in this report.
Besides, the analyst confirms that neither the analyst nor his/her associates (as defined in the code of conduct issued by The Hong Kong Securities
and Futures Commission) (1) have dealt in or traded in the stock(s) covered in this research report within 30 calendar days prior to the date of issue
of this report; (2) will deal in or trade in the stock(s) covered in this research report 3 business days after the date of issue of this report; (3) serve
as an officer of any of the Hong Kong listed companies covered in this report; and (4) have any financial interests in the Hong Kong listed companies
covered in this report.
CMBIS Ratings
BUY
: Stock with potential return of over 15% over next 12 months
HOLD
: Stock with potential return of +15% to -10% over next 12 months
SELL
: Stock with potential loss of over 10% over next 12 months
NOT RATED
: Stock is not rated by CMBIS
OUTPERFORM
: Industry expected to outperform the relevant broad market benchmark over next 12 months
MARKET-PERFORM
: Industry expected to perform in-line with the relevant broad market benchmark over next 12 months
UNDERPERFORM
: Industry expected to underperform the relevant broad market benchmark over next 12 months
CMB International Securities Limited
CMB International Securities Limited ("CMBIS") is a wholly owned subsidiary of CMB International Capital Corporation Limited (a wholly owned subsidiary
of China Merchants Bank)
Important Disclosures
There are risks involved in transacting in any securities. The information contained in this report may not be suitable for the purposes of all investors. CMBIS
does not provide individually tailored investment advice. This report has been prepared without regard to the individual investment objectives, financial position
or special requirements. Past performance has no indication of future performance, and actual events may differ materially from that which is contained in
the report. The value of, and returns from, any investments are uncertain and are not guaranteed and may fluctuate as a result of their dependence on the
performance of underlying assets or other variable market factors. CMBIS recommends that investors should independently evaluate particular investments
and strategies, and encourages investors to consult with a professional financial advisor in order to make their own investment decisions.
This report or any information contained herein, have been prepared by the CMBIS, solely for the purpose of supplying information to the clients of CMBIS or
its affiliate(s) to whom it is distributed. This report is not and should not be construed as an offer or solicitation to buy or sell any security or any interest in
securities or enter into any transaction. Neither CMBIS nor any of its affiliates, shareholders, agents, consultants, directors, officers or employees shall be
liable for any loss, damage or expense whatsoever, whether direct or consequential, incurred in relying on the information contained in this report. Anyone
making use of the information contained in this report does so entirely at their own risk.
The information and contents contained in this report are based on the analyses and interpretations of information believed to be publicly available and reliable.
CMBIS has exerted every effort in its capacity to ensure, but not to guarantee, their accuracy, completeness, timeliness or correctness. CMBIS provides the
information, advices and forecasts on an "AS IS" basis. The information and contents are subject to change without notice. CMBIS may issue other
publications having information and/ or conclusions different from this report. These publications reflect different assumption, point-of-view and analytical
methods when compiling. CMBIS may make investment decisions or take proprietary positions that are inconsistent with the recommendations or views in
this report.
CMBIS may have a position, make markets or act as principal or engage in transactions in securities of companies referred to in this report for itself and/or
on behalf of its clients from time to time. Investors should assume that CMBIS does or seeks to have investment banking or other business relationships with
the companies in this report. As a result, recipients should be aware that CMBIS may have a conflict of interest that could affect the objectivity of this report
and CMBIS will not assume any responsibility in respect thereof. This report is for the use of intended recipients only and this publication, may not be
reproduced, reprinted, sold, redistributed or published in whole or in part for any purpose without prior written consent of CMBIS.
Additional information on recommended securities is available upon request.
For recipients of this document in the United Kingdom
(as amended from time to time) ("The Order") or (II) are persons falling within Article 49(2) (a) to (d) ("High Net Worth Companies, Unincorporated Associations,
etc.,) of the Order, and may not be provided to any other person without the prior written consent of CMBIS.
For recipients of this document in the United States
This report is intended for distribution in the United States to "major US institutional investors", as defined in Rule 15a-6 under the US, Securities Exchange
Act of 1934, and may not be furnished to any other person in the United States. Each major US, institutional investor that receives a copy of this research
report by its acceptance hereof represents and agrees that it shall not distribute or provide this research report to any other person.
For recipients of this document in Singapore
This report is distributed in Singapore by CMBI (Singapore) Pte. Limited (CMBISG) (Company Regn. No. 201731928D), an Exempt Financial Adviser as
defined in the Financial Advisers Act (Cap. 110) of Singapore and regulated by the Monetary Authority of Singapore. CMBISG may distribute reports produced
by its respective foreign entities, affiliates or other foreign research houses pursuant to an arrangement under Regulation 32C of the Financial Advisers
Regulations. Where the report is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, as defined
in the Securities and Futures Act (Cap. 289) of Singapore, CMBISG accepts legal responsibility for the contents of the report to such persons only to the
extent required by law. Singapore recipients should contact CMBISG at +65 6350 4400 for matters arising from, or in connection with the report.